Member Info for Cliostock

ElonMusky, given your experiences throughout your investment in OPTI and watching the regression once you divested, I can see why you feel the way you do and it’s noble of your to take the time to post the cautionary tale.

However, I would counter that OPTI is a world away from SBTX because of the involvement and commitment of Croda. Now, if we were 2/3 years into Axis, with little sales, no sign of a MN deal, and raising yearly to fund R+D that might not go anywhere, and if it does it’s years later, then I would agree with your comparisons. However Croda is about to launch a product which has near guaranteed success, which will provide a decent revenue stream, and if Ashman is to be believed, the Axis pillar is currently under the scrutiny of PLC’s that can drive its success.

I invested in SBTX because I was interested in this royalty collecting business model, and for that the board should be sufficient. Granted, they are doing their best to prove me wrong at the moment. But nothing in business is easy, nor linear. It sounds like Ashman is hoping for several pieces of news imminently to explore in his IMC presentation. If we get what we hope for, some forecasts, the CB clearing and a certified Croda launch, there is no reason the SP couldn’t be 30p+ in the short term, and picking up as we learn about Croda’s progress with lysate sales and the other irons in the fire developing some of which are quite exciting.

I think SA has eluded to the fact he has learnt his lesson on this in one of the interviews. I believe he said he would insert clauses meaning payments for extensions too.

Excellent work Aquae and diligently put together. Not long now until this should all be out in the open. Fingers crossed SA recognises the gaps in knowledge that may have arisen for even keen LTH such as myself, as you have done, and provides answers suitable to clearly restate the case of the company and its technology as an investment proposition. After all, it has been a looooooong time coming since those heady days of 75p when we were led to expect a flood of imminent opportunity. When listening to SA in any presentation or interview, and when reading your latest summary, I see no reason why this is still not the case. My groundworks comments come because the SP is telling us the market is at the end of its tether in terms of realisation of some of the opportunities.

You invested in this company recently, rather desperately and without much confidence?

You sound like a used car salesman’s dream.

We have long had information that the lysate is a bit of a Swiss Army knife for repairing and protecting skin, opportunities have long been aplenty. I recognise we have been waiting for Croda to finish their work so the manufacturing begins, but I sincerely hope groundwork has been laid for various offshoots of commercialisation since as far back as the Manchester meet when we were told of the potential within.

Disco I’d suggest it depends on how much of what SA has previously said is hard fact and what is exaggeration. We have previously been told there are multiple interested parties, which would usually mean at least one would be trying to close a deal fast to beat the competition. I doubt SA would be the one holding a deal off particularly given the SP decline over the last few years. It has been said for a long time the multinationals, plural, need to see that SBTX is not a one trick pony. The acne study proves this along with the Psoriasis product and the ongoing successful work with Croda and with the oral and inflammation research.

I wouldn’t expect SA to have a deal sewn up too soon, it will be fairly complicated and we already know these things take time. What I would certainly expect is for SA to let us know in his IMC presentation is what the reasonable next steps are to successfully commercialising the product and bringing in revenue to SBTX. Has a partner been selected/ how far on are the discussions/ has a structure and any numbers been discussed, and eventually, some forecasts, which any large company taking a whole pillar should be able to provide in advance. In fact, SA would be crazy to do a deal for such a large chunk of the company’s prospects without studying said forecasts. Fingers crossed we’ll know most of the above in the next 10 days.

I wouldn’t suggest that is any kind of cause for concern Prospector, I’ve seen IMC presentations come about with only a couple of days notice. The 1st August is probably just the furthest in the future that IMC have a confirmed one booked in.

Yes it has to be the CB’s. LTH’s have seen how quick SBTX moves at the kind of volumes shown recently, we have seen 20% rises in a day with these kind of share purchases. And if the recent late reported trades are the CB’s, it should be down to less than 500k by my calculations. It could even be clear by the end of the month if the trend continues.

Yes, the brain of a spoilt child, that’s a good way of putting it Farris. It’s as though when he speaks, he says what he thinks makes him look good, with absolutely no interest in the truth whatsoever. Classic case of urinating on his crowds, and telling them it’s raining.

Wow is the OPTI SP down to 18p now, it was around 30p last time I was aware. SOH did do a good job of that reach RNS though!

Leapfroggy I’m certainly no expert on the matter but I imagine it makes for a double bubble for them. Convert their shares for profit which damages the SP and a shorter profits from a damaged SP. Some ‘partner’.

Wow that’s poor trolling Musky. Using a 5 year old link. You might as well post a snippet from Ashman’s school report!

Superb, potentially another £80k cleared then.

Can anyone shed any light on the large trades reported today?

Thanks for that summary of your point of view Toyin, understandable and logical. Totally agree with your final statement. Fingers crossed.

Fingers crossed Toyin. It would be great to see the CLNs gone by the time Croda launches so there is nothing to hold us back and no uncertainty about which easy the fortunes of the company are moving in.

I agree TC

There’s obviously some doom and gloom in the air, but someone always takes it too far into the realms of idiocy. Christ on a bike! If the shares are 4 decimal points to the right of a penny by Christmas I’ll buy every last one, take the Croda royalties and sell axis at the car boot.

There are distinct reasons to be unhappy here. One of them is that now and again Ashman does a presentation which sounds brilliant and settles the nerves and then achieves absolutely nothing in the meantime until he needs to do another presentation, and the cycle is getting tiring and insulting.

BUT the company is funded, we still have Croda coming, acne coming, oral trial coming and Dermatonics and UMG. Investors have every right to be highly disappointed - but I’d be embarrassed posting those figures with any kind of seriousness.

I’m a big fan of the potential within this company, but it’s impossible to disagree with you Bazzaman. The team are either letting us down with their lack of successful commercialisation of that potential, or they are simply not bothering to communicate any good work properly with shareholders; the latter being a previous issue and something we have been assured would not continue to happen.

I’m really surprised the board have left shareholders in a position where the SP is languishing in single figures for so long when it should be up at 30,40,50p. It is giving the impression they are helpless and if that’s the case we have to seriously question if their interests align with ours. Their wages are advantageous enough for them even if they achieve nothing.

We’ve been told so many times Croda is out of the control of the board, maybe that’s a good thing looking at how Axis/Acne is being handled. I’m starting to become bemused by the team that tells us they are amazing whilst producing practically nothing tangible. I’m sure I’m not alone in that I have been patient and understanding for a period of years now.

Elrico, do you mean UMG as a partner on Axis? No doubt they would do a good job of it in their home regions but does that not just make them a distributor, the route that we shunned for a global multinational years ago?